CASI Pharmaceuticals Announces Third Quarter 2020 Financial Results

ROCKVILLE, Md. and BEIJING, Nov. 9, 2020 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results and business highlights for…

About the Author

has written 39704 stories on this site.

Copyright © 2010 Business and Corporate News.